Drug
Calcipotriol Hydrate Daivonex
Calcipotriol Hydrate Daivonex: highest development phase Post-Market, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| calcipotriol hydrate [Daivonex] NCT00437619 | Post-Market | Psoriasis |
Latest
No recent events.
Follow Calcipotriol Hydrate Daivonex on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.